首页> 美国卫生研究院文献>Gut >Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial
【2h】

Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial

机译:幽门螺杆菌测试及根除术与即时内镜检查对消化不良患者的处理:一项为期6.7年的随机试验随访

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Dyspepsia is a chronic disease with significant impact on the use of health care resources. A management strategy based on Helicobacter pylori testing has been recommended but the long term effect is unknown.>Aim: To investigate the long term effect of a test and treat strategy compared with prompt endoscopy for management of dyspeptic patients in primary care.>Patients: A total of 500 patients presenting in primary care with dyspepsia were randomised to management by H pylori testing plus eradication therapy (n = 250) or by endoscopy (n = 250). Results of 12 month follow up have previously been presented.>Methods: Symptoms, quality of life, and patient satisfaction were recorded during a three month period, a median 6.7 years after randomisation (range 6.1–7.3 years). Number of endoscopies, antisecretory medication, H pylori treatments, and hospital visits were recorded from health care databases for the entire follow up period.>Results: Median age was 45 years; 28% were H pylori infected. Use of resources was registered in all 500 patients (3084 person years) of whom 312 completed diaries. We found no difference in symptoms between the two groups. Median proportion of days without symptoms was 0.52 (interquartile range 0.10–0.88) in the test and eradicate group versus 0.64 (0.14–0.90) in the prompt endoscopy group (p = 0.27) (mean difference 0.05 (95% confidence interval (CI) −0.03 to 0.14)). Compared with the prompt endoscopy group, the test and eradicate group underwent fewer endoscopies (mean difference 0.62 endoscopies/person (95% CI 0.38–0.86)) and used less antisecretory medication (mean difference 102 defined daily doses/person (95% CI −1 to 205)).>Conclusion: On a long term basis, a H pylori test and eradicate strategy is as efficient as prompt endoscopy for management of dyspeptic patients in primary care and reduces the use of endoscopy and antisecretory medication.
机译:>背景:消化不良是一种慢性疾病,对医疗资源的使用产生重大影响。推荐了一种基于幽门螺杆菌检测的治疗策略,但长期效果尚不明确。>目的:研究与快速内镜相比,测试和治疗策略对消化不良患者的长期治疗效果。 >患者:总共有500名就诊的消化不良患者,通过幽门螺杆菌检测加根除治疗(n = 250)或通过内窥镜检查(n = 250)进行治疗。 >方法:在三个月的时间内记录了症状,生活质量和患者满意度,这是随机分配后的中位时间6.7年(范围为6.1-7.3年)。 。在整个随访期间,从医疗保健数据库中记录了内镜检查,抗分泌药物治疗,幽门螺杆菌治疗和医院就诊的次数。>结果:中位年龄为45岁;幽门螺杆菌感染占28%。在所有500名患者(3084人年)中登记了资源的使用,其中312名完成了日记。我们发现两组之间的症状没有差异。试验和根除组中无症状的天数中位数比例为0.52(四分位间距0.10-0.88),而快速内镜组(poscopy = 0.27)为0.64(0.14-0.90)(平均差异0.05(95%置信区间(CI)) -0.03至0.14))。与即刻内窥镜检查组相比,测试和根除组的内镜检查较少(平均差异为0.62内窥镜检查/人(95%CI 0.38–0.86)),使用的抗分泌药物较少(平均差异102定义为每日剂量/人(95%CI- 1到205)。>结论:从长远来看,幽门螺杆菌检测和根除策略与及时内镜治疗基层消化不良患者的治疗一样有效,并减少了内镜和抗分泌药的使用药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号